Literature DB >> 31807527

Value of computed tomography evaluation in pathologic classification and prognosis prediction of gastric neuroendocrine tumors.

Shida Yan1, Tongtong Liu2, Ying Li3, Yongjian Zhu3, Jun Jiang3, Liming Jiang3, Hong Zhao1.   

Abstract

BACKGROUND: The study aims to investigate the correlation of CT characteristics with pathological classifications and the prognostic value of CT features in patients with gastric neuroendocrine neoplasms (g-NENs).
METHODS: Ninety-one cases of pathologically diagnosed g-NENs, including 15 cases of well-differentiated neuroendocrine tumors (NETs) (G1 and G2) and 76 cases of poor-differentiated neuroendocrine carcinomas (NECs) (G3 and MANEC) were retrospectively studied. All cases were included in correlation analysis of CT characteristics with pathologic grades. Among them, 76 patients who had fulfilled follow-up data were included for overall survival (OS) and disease-free survival (DFS) analysis.
RESULTS: CT characteristics that favor poor differentiation include tumor location (fundus and cardia), larger tumor size (>3.0 cm), infiltrative growth, unclear tumor margin, serosa involvement, ulceration and lymph node metastasis (P<0.05). Most variables had sensitivities >80% and specificities >60% to distinguish NECs from NETs. Through log-rank analysis, it was revealed that serosa involvement, cystic degeneration, necrosis, heterogeneous enhancement and lymph node metastasis led to worse DFS and OS for patients with g-NENs (P<0.05). COX regression analysis showed that serosa involvement and lymph node metastasis were independent risk factor for DFS and OS, respectively, despite of grading, staging and therapeutic choices (P<0.05). Moreover, high Ki-67 index (>55%) in G3 g-NENs is in correlation with serosa involvement and lymph node metastasis; accordingly, patients with higher Ki-67 index had worse 1-year DFS (61.7% vs. 92.3%; P<0.05).
CONCLUSIONS: CT characteristics can be useful discriminators and prognostic factors for g-NENs and may help identify G3 g-NEC from G3 g-NEN by revealing its poor differentiation and high invasive potential. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Stomach neoplasms; multidetector computed tomography (CT); neuroendocrine tumors (NETs); pathology; survival analysis

Year:  2019        PMID: 31807527      PMCID: PMC6861764          DOI: 10.21037/atm.2019.09.114

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  29 in total

1.  Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer.

Authors:  Takuro Saito; Yukinori Kurokawa; Shuji Takiguchi; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Makoto Yamasaki; Hiroshi Miyata; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

Review 2.  The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.

Authors:  Halfdan Sorbye; Eric Baudin; Aurel Perren
Journal:  Endocrinol Metab Clin North Am       Date:  2018-07-11       Impact factor: 4.741

3.  CT evaluation of gastroenteric neuroendocrine tumors: relationship between ct features and the pathologic classification.

Authors:  Shi-Ting Feng; Yanji Luo; Tao Chan; Zhenpeng Peng; Jie Chen; Minhu Chen; Zi-Ping Li
Journal:  AJR Am J Roentgenol       Date:  2014-09       Impact factor: 3.959

4.  CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas.

Authors:  Seong Ho Kim; Se Hyung Kim; Min-A Kim; Cheong-il Shin; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

5.  Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).

Authors:  Halfdan Sorbye; Eric Baudin; Ivan Borbath; Martyn Caplin; Jie Chen; Jaroslaw B Cwikla; Andrea Frilling; Ashley Grossman; Gregory Kaltsas; Aldo Scarpa; Staffan Welin; Rocio Garcia-Carbonero
Journal:  Neuroendocrinology       Date:  2018-08-28       Impact factor: 4.914

Review 6.  From the archives of the AFIP: Gastrointestinal carcinoids: imaging features with clinicopathologic comparison.

Authors:  Angela D Levy; Leslie H Sobin
Journal:  Radiographics       Date:  2007 Jan-Feb       Impact factor: 5.333

7.  Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors.

Authors:  Gaspard d'Assignies; Anne Couvelard; Stéphane Bahrami; Marie-Pierre Vullierme; Pascal Hammel; Olivia Hentic; Alain Sauvanet; Pierre Bedossa; Philippe Ruszniewski; Valérie Vilgrain
Journal:  Radiology       Date:  2008-12-18       Impact factor: 11.105

8.  Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.

Authors:  Cheng Fang; Wei Wang; Yu Zhang; Xingyu Feng; Jian Sun; Yujie Zeng; Ye Chen; Yong Li; Minhu Chen; Zhiwei Zhou; Jie Chen
Journal:  Chin J Cancer       Date:  2017-06-21

9.  Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population-based study.

Authors:  Fang-Xi Tian; Yu-Qing Cai; Lv-Ping Zhuang; Ming-Fang Chen; Zhong-Biao Xiu; Yi Zhang; Hong Liu; Zhi-Hong Liu; Guo-Ping Liu; Chen Zeng; Fei-Ling Lin; Jing Liu; Si-Ting Huang; Liang-Zhi Zhang; Hua-Yang Lin
Journal:  Cancer Med       Date:  2018-10-11       Impact factor: 4.452

10.  Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.

Authors:  Chaoyong Shen; Huijiao Chen; Haining Chen; Yuan Yin; Luyin Han; Jiaju Chen; Sumin Tang; Xiaonan Yin; Zongguang Zhou; Bo Zhang; Zhixin Chen
Journal:  BMC Gastroenterol       Date:  2016-09-09       Impact factor: 3.067

View more
  2 in total

Review 1.  Gastric neuroendocrine neoplasms: a primer for radiologists.

Authors:  Molly E Roseland; Isaac R Francis; Kimberly L Shampain; Erica B Stein; Ashish P Wasnik; John D Millet
Journal:  Abdom Radiol (NY)       Date:  2022-04-12

Review 2.  New Developments in Gastric Neuroendocrine Neoplasms.

Authors:  Klaire Exarchou; Nathan A Stephens; Andrew R Moore; Nathan R Howes; D Mark Pritchard
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.